Wednesday, November 26, 2025
TraderNews
  • Home
  • Companies & Earnings
    • Corporate News
    • IPOs & Listings
    • Mergers & Acquisitions
    • Quarterly Earnings Reports
  • Cryptocurrency
    • Altcoins (Ethereum, Solana, etc.)
    • Bitcoin
    • DeFi & Web3
    • NFTs & Digital Assets
  • Investing Strategies
    • Growth Investing
    • Passive vs Active Investing
    • Portfolio Management
  • Markets
    • Bonds & Fixed Income
    • Commodities
    • Foreign Exchange (Forex)
    • Stock Market
No Result
View All Result
  • Home
  • Companies & Earnings
    • Corporate News
    • IPOs & Listings
    • Mergers & Acquisitions
    • Quarterly Earnings Reports
  • Cryptocurrency
    • Altcoins (Ethereum, Solana, etc.)
    • Bitcoin
    • DeFi & Web3
    • NFTs & Digital Assets
  • Investing Strategies
    • Growth Investing
    • Passive vs Active Investing
    • Portfolio Management
  • Markets
    • Bonds & Fixed Income
    • Commodities
    • Foreign Exchange (Forex)
    • Stock Market
No Result
View All Result
TraderNews
No Result
View All Result
Home Companies & Earnings IPOs & Listings

TRESU Investment Holding A/S – Announcement of Q3 2025

admin by admin
November 26, 2025
in IPOs & Listings
0
TRESU Investment Holding A/S – Announcement of Q3 2025
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


TRESU INVESTMENT HOLDING A/S
ANNOUNCEMENT NO. 14.2025
26.11.2025

TRESU Investment Holding A/S – Announcement of Q3 2025 Interim Report

Tresu Investment Holding A/S today publishes the Q3 2025 Interim Report and presentation of the financial results.

We are pleased to invite you to the financial results call, which is being held

                                             Tuesday, 2. December 2025, at 10am CET.

The Interim Report will be presented by Stephan Plenz, CEO and Jesper Eriksen, CFO. After the presentations there will be an opportunity for Q+A.

A recording of the results call will be made available for four hours on the TRESU IR website.

To register for the investor call, please send an e-mail to fho@tresu.com directed to Financial Manager at TRESU A/S, Finn Holm, no later than 1. December 2025 9am CET.

Stephan plenz
CEO, TRESU

For further details, please contact:
CEO, Stephan Plenz, phone: +45 2194 5480
CFO, Jesper Eriksen, phone: +45 6073 1967

Attachments:

TRESU Investment Holding AS interim report 2025 Q3

Quarterly reporting – 2025 Q3

  • Tresu Investment Holding interim report 2025 Q3
  • Quarterly reporting – 2025 Q3



Source link

Previous Post

Li Auto Inc. Announces Unaudited Third Quarter 2025

Next Post

WSPN Brings Institutional Treasury Yields to Stablecoin Holders with W Earn Launch

admin

admin

Related Posts

Transactions under share buy-back programme
IPOs & Listings

Transactions under share buy-back programme

by admin
November 26, 2025
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare
IPOs & Listings

Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare

by admin
November 26, 2025
Teva obtient les autorisations de la Commission européenne
IPOs & Listings

Teva erhält Zulassung der Europäischen Kommission für

by admin
November 26, 2025
Faircourt Asset Management Inc. Announces November
IPOs & Listings

Faircourt Asset Management Inc. Announces November

by admin
November 26, 2025
Faraday Future Founder and Co-CEO YT Jia Shares Weekly
IPOs & Listings

Leaders from FF and FX Attend the Ras Al Khaimah Investment

by admin
November 26, 2025
Next Post
WSPN Brings Institutional Treasury Yields to Stablecoin Holders with W Earn Launch

WSPN Brings Institutional Treasury Yields to Stablecoin Holders with W Earn Launch

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Premium Content

Ripple vs. SEC Is Over: Time to Challenge SWIFT?

Ripple vs. SEC Is Over: Time to Challenge SWIFT?

September 7, 2025
The Discounted Cash Flow Dilemma: A Tool for Theorists or Practitioners?

The Discounted Cash Flow Dilemma: A Tool for Theorists or Practitioners?

November 24, 2025
Innova Therapeutics impulsará un nuevo tratamiento contra el cáncer con la adquisición de Enci Therapeutics

Innova Therapeutics impulsará un nuevo tratamiento contra el cáncer con la adquisición de Enci Therapeutics

November 25, 2025

Browse by Category

  • Altcoins (Ethereum, Solana, etc.)
  • Bitcoin
  • Bonds & Fixed Income
  • Corporate News
  • DeFi & Web3
  • Foreign Exchange (Forex)
  • Growth Investing
  • IPOs & Listings
  • Mergers & Acquisitions
  • Passive vs Active Investing
  • Portfolio Management
  • Quarterly Earnings Reports
  • Stock Market
My Blog

TraderNews is an automated news hub for investors and traders. We aggregate headlines, filings, and market stories from trusted sources and organize them into Markets, Companies & Earnings, Cryptocurrency, and Investing Strategies updated all day, every day.

Categories

  • Altcoins (Ethereum, Solana, etc.)
  • Bitcoin
  • Bonds & Fixed Income
  • Corporate News
  • DeFi & Web3
  • Foreign Exchange (Forex)
  • Growth Investing
  • IPOs & Listings
  • Mergers & Acquisitions
  • Passive vs Active Investing
  • Portfolio Management
  • Quarterly Earnings Reports
  • Stock Market

Recent Posts

  • Spain Proposes Crypto Tax Hike and New Risk Rules, Sparking Backlash
  • Grayscale’s GDOG Debuts Quietly While DOGE Builds Higher Lows
  • Crypto Markets Drop as Investors Eye House Vote and Inflation Data

© 2025 TraderNews

No Result
View All Result
  • Home
  • Companies & Earnings
    • Corporate News
    • IPOs & Listings
    • Mergers & Acquisitions
    • Quarterly Earnings Reports
  • Cryptocurrency
    • Altcoins (Ethereum, Solana, etc.)
    • Bitcoin
    • DeFi & Web3
    • NFTs & Digital Assets
  • Investing Strategies
    • Growth Investing
    • Passive vs Active Investing
    • Portfolio Management
  • Markets
    • MCRP
    • Bonds & Fixed Income
    • Commodities
    • Foreign Exchange (Forex)
    • Stock Market

© 2025 TraderNews

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?